// App-Quantinova.ai

: CAPTAIN: Effects of Cardiovascular Risk on Response to Triple Therapy in Patients With Inadequately Controlled Asthma on Inhaled Corticosteroids/Long-acting β2-agonists (ICS/LABA)

Researchers

Presenter

  • Nicola Hanania

Principal Investigators

  • Zelie Bailes

  • Sarah Chang

  • Andrew Fowler

  • Robson Lima

  • David Mannino

  • Mark Millard

  • Joseph Spahn

  • Steve Weinstein

  • Robert Nathan

Medical Centers

  • GSK, Stockley Park West, Uxbridge, Middlesex, United Kingdom,

  • GSK, Research Triangle Park, NC, USA

  • Baylor Scott & White Texas Lung Center, Dallas, TX, USA

  • Allergy and Asthma Specialists Medical Group and Research Center, Huntington Beach, United States of America

  • Asthma and Allergy Associates, P.C. and Research Center, Colorado Springs, CO, United States,

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Genetic Disorder

Disease

  • Congestive heart failure

  • Ischemic stroke

  • Coronary Artery Disease

  • Myocardial infarction

  • Hypercholesterolemia, Familial, 1

  • Hypertension

  • Arrhythmia

  • Diabetes

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Umeclidinium

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Controlled

  • Parallel Group

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved